SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-21-000003
Filing Date
2021-01-08
Accepted
2021-01-08 16:03:39
Documents
4
Period of Report
2021-01-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ngio010821form8k.htm 8-K 28819
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 1526
3 GRAPHIC image_002.gif GRAPHIC 14629
4 GRAPHIC image_001.gif GRAPHIC 4696
  Complete submission text file 0001607062-21-000003.txt   58052
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 (416) 364-2551
NUGENEREX IMMUNO-ONCOLOGY, INC. (Filer) CIK: 0001804585 (see all company filings)

IRS No.: 043208418 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-56153 | Film No.: 21517491
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences